Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Implementation of the German Guideline for the Prevention, Diagnosis, Treatment, and Follow-up of Lung Cancer in the Federal State of Berlin].

Pneumologie (Stuttgart, Germany)·2012
Same author

[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].

Pneumologie (Stuttgart, Germany)·2011
Same author

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society.

Pneumologie (Stuttgart, Germany)·2010
Same author

[Prevention, diagnosis, therapy, and follow-up of lung cancer].

Pneumologie (Stuttgart, Germany)·2010
Same author

[Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD)].

Pneumologie (Stuttgart, Germany)·2003
Same author

[Evolutionary quality control of diagnostics and therapy in hospitals].

Pneumologie (Stuttgart, Germany)·2002

Related Experiment Videos

[Lung cancer - historical development, current status, future prospects].

G Goeckenjan1

  • 1GGoeckenjan@t-online.de

Pneumologie (Stuttgart, Germany)
|September 10, 2010
PubMed
Summary

Lung cancer is now the leading cause of cancer death globally due to increased smoking. While treatments have improved, more effective therapies and preventative strategies are crucial for better lung cancer survival rates.

Related Experiment Videos

Area of Science:

  • Oncology
  • Public Health

Context:

  • Lung cancer incidence has dramatically increased globally, largely attributed to rising tobacco smoking rates.
  • Early-stage lung cancer is often asymptomatic, leading to diagnoses at advanced stages (IIIB or IV).
  • Advances in diagnostic imaging and staging have improved tumor classification.

Purpose:

  • To review the current landscape of lung cancer diagnosis, treatment, and prevention.
  • To highlight the impact of smoking on lung cancer mortality.
  • To discuss the efficacy of current therapeutic strategies and the need for novel approaches.

Summary:

  • Surgical mortality for lung cancer has decreased, but 5-year survival rates remain low.
  • For unresectable non-small cell lung cancer, radiotherapy and chemoradiotherapy offer moderate prognostic improvement.
  • Chemotherapy provides moderate life extension and improved quality of life for non-small cell lung cancer patients.
  • Chemotherapy has significantly improved survival for small cell lung cancer since the 1970s, with limited recent progress.
  • Avoiding tobacco smoke is the most effective preventive measure.
  • Screening with chest X-ray and sputum cytology has not reduced overall mortality; low-dose CT screening efficacy is under investigation.

Impact:

  • Current treatments offer moderate benefits, emphasizing the urgent need for more effective lung cancer therapies.
  • Public health initiatives focusing on smoking cessation are paramount for primary prevention.
  • Ongoing research into screening methods like low-dose CT may offer future improvements in early detection and prognosis.